Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WATERLAND
NCT05781243Phase 4Completed
- Start
- Jun 2023
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactated ringer's solution in acute pancreatitis (AP) (2 arms). Primary endpoint: Number of Participants with moderately severe or severe acute pancreatitis at 30 days. Started Jun 2023; status: completed.
02
Drugs
lactated ringer's solution
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT05781243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05781243.